Literature DB >> 31688672

CHOROIDAL LESIONS UNRESPONSIVE TO FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN BIRDSHOT CHORIORETINOPATHY.

Shuk Kei Cheng1, Ian Thompson, Chinwenwa Okeagu, H Nida Sen.   

Abstract

PURPOSE: To report the persistence of choroidal lesions despite fluocinolone acetonide intravitreal implants and their resolution with oral prednisone treatment.
METHODS: Retrospective chart review of a birdshot chorioretinopathy patient at a tertiary referral clinic.
RESULTS: Indocyanine angiography revealed resolution of choroidal lesions with oral prednisone and recurrence after discontinuation of oral prednisone.
CONCLUSION: Choroidal lesions responded to oral prednisone despite bilateral active fluocinolone acetonide intravitreal implant in a birdshot chorioretinopathy patient.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 31688672      PMCID: PMC7190444          DOI: 10.1097/ICB.0000000000000909

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  18 in total

1.  Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device.

Authors:  Ryan B Rush; Debra A Goldstein; David G Callanan; Beeran Meghpara; William J Feuer; Janet L Davis
Journal:  Am J Ophthalmol       Date:  2011-02-01       Impact factor: 5.258

2.  INTRAVITREAL DEXAMETHASONE IMPLANTATION FOR BIRDSHOT CHORIORETINOPATHY.

Authors:  James Walsh; Ashvini K Reddy
Journal:  Retin Cases Brief Rep       Date:  2017 Winter

3.  Longitudinal cohort study of patients with birdshot chorioretinopathy. I. Baseline clinical characteristics.

Authors:  Dominique Monnet; Antoine P Brézin; Gary N Holland; Fei Yu; Alfred Mahr; Lynn K Gordon; Ralph D Levinson
Journal:  Am J Ophthalmol       Date:  2006-01       Impact factor: 5.258

4.  Choroidal abnormalities in birdshot chorioretinopathy: an indocyanine green angiography study.

Authors:  L J Howe; M R Stanford; E M Graham; J Marshall
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

5.  Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen.

Authors:  R B Nussenblatt; K K Mittal; S Ryan; W R Green; A E Maumenee
Journal:  Am J Ophthalmol       Date:  1982-08       Impact factor: 5.258

6.  Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy.

Authors:  Asima Bajwa; Kanza Aziz; C Stephen Foster
Journal:  Retina       Date:  2014-11       Impact factor: 4.256

7.  CLINICOPATHOLOGICAL CORRELATION IN A PATIENT WITH PREVIOUSLY TREATED BIRDSHOT CHORIORETINOPATHY.

Authors:  Elliott H Sohn; Kathleen R Chirco; James C Folk; Robert F Mullins
Journal:  Retin Cases Brief Rep       Date:  2017 Fall

8.  BIRDSHOT CHORIORETINITIS LESIONS ON INDOCYANINE GREEN ANGIOGRAPHY AS AN INDICATOR OF DISEASE ACTIVITY.

Authors:  Jennifer H Cao; Sukhum Silpa-Archa; Clovis A Freitas-Neto; C Stephen Foster
Journal:  Retina       Date:  2016-09       Impact factor: 4.256

Review 9.  Birdshot retinochoroidopathy.

Authors:  Albert T Vitale
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

Review 10.  Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment.

Authors:  Evangelos Minos; Robert J Barry; Sue Southworth; Annie Folkard; Philip I Murray; Jay S Duker; Pearse A Keane; Alastair K Denniston
Journal:  Orphanet J Rare Dis       Date:  2016-05-12       Impact factor: 4.123

View more
  1 in total

Review 1.  Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.

Authors:  Ioannis Papasavvas; Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.